Benign Prostatic Hyperplasia and the Risk of Prostate Cancer... : Medicine Benign Prostatic
Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of …

BACKGROUND Pathologically, benign prostatic hyperplasia (BPH) is not considered a
precursor for prostate carcinoma. However, because the two conditions share not only a …

This study examined the association between symptomatic benign prostatic hyperplasia
(BPH) and prostate cancer risk in 5,068 placebo-arm participants enrolled in the Prostate …

CONTEXT: More than half the male population aged> 50 yr have histologic evidence of
benign prostatic hyperplasia (BPH), while prostate cancer (PCa) is among the most common …

We evaluated the risk of bladder cancer in a cohort of 79 280 Swedish men hospitalised for
benign prostatic hyperplasia (BPH), identified in the Swedish Inpatient Register between …

Benign prostatic hyperplasia (BPH) and prostate cancer are among the most common
diseases of the prostate gland and represent significant burdens for patients and health-care …

There are a number of similarities between benign prostatic hyperplasia (BPH) and cancer.
Both display a parallel increase in prevalence with patient age according to autopsy studies …

Benign prostatic hyperplasia refers to an anatomic diagnosis, yet in practice it is typically
diagnosed clinically on the basis of lower urinary tract symptoms and prostatic enlargement …

Despite being such a common condition, morphologically prevalent in 88% of autopsies of
old (> 80 years) men, little epidemiologic research has been undertaken on benign prostatic …

Benign prostatic hyperplasia (BPH) is a prevalent condition in aging men that represents a
substantial disease burden. It can be associated with various other health outcomes that can …